Posted on 05/01/2009 1:46:38 PM PDT by JoeProBono
Consumers using Hydroxycut products should immediately stop taking the dietary supplements, the Food and Drug Administration warned today after receiving reports of serious health problems related to the drugs. Hydroxycut The dietary supplements -- made by Iovate Health Sciences Inc. of Oakville in Ontario, Canada, and distributed by Iovate Health Sciences USA Inc. of Blasdell, N.Y. -- have been linked to one death and are associated with several serious liver injuries, the FDA said. Iovate has agreed to recall the products from the market. The FDA has received 23 reports of serious health problems including jaundice, elevated liver enzymes and liver damage requiring liver transplant. Other health problems reported included seizures, cardiovascular disorders and rhabdomyolysis, a type of muscle damage that can lead to other serious health problems such as kidney failure.
(Excerpt) Read more at latimesblogs.latimes.com ...
Is it just me, or does it look like they put that woman through a photo processing program?
Oh great! I took Hydroxycut in 1997-1998. And that was with the ephedra. Lost 80 pounds. Have since gained it back when I quit smoking.
Another “magical” weight loss pill where the “cure” is worse than the disease. Want to lose weight? Avoid refined carbohydrates (white flour, sugar and high fructose corn syrup).
Will Obama send me a check to make up for my loss? Its HIS Food and Drug Administration after all...
When the FDA issues a warning, it usually means the product works.
When the FDA tells people to stop taking the pill because a bunch of women have died while doing so, or taking RU-486, and demands they pull this stuff off the shelf, maybe then they will have some credibility for being consistent.
Until then, get bent FDA.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.